1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
Hemostatic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2022

Hemostatic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2022

  • November 2018
  • 435 pages
  • ID: 5687310
  • Format: PDF
  • Transparency Market Research
Up to $2949 off Until Sep 30th 2021

Summary

Table of Contents

Hemostatic Agents Market - Overview

Hemostasis is the physiological process to stop the bleeding, or blood flow via a blood vessel, or hemorrhage.A clot is formed at injury site in hemostasis and results in repairing of blood vessels.

The main components of hemostasis are primary hemostasis, secondary hemostasis, and fibrinolysis.At the time of a blood vessel injury, platelets gather together to form a plug.

In hemostasis, an interaction of proteins, known as clotting factors, forms a fibrin mesh to hold the platelets intact, thereby resulting in the injury healing while not letting the blood escape from the blood vessel.Hemostatic agents are utilized to stem blood flow and enhance clotting and hemostasis by speeding up the coagulation process.

These agents enhance hemostasis by progressing primary hemostasis, boosting the formation of fibrin, or inhibiting fibrinolysis. Hemostatic agents play a prominent and vital role in the treatment or prevention of excessive or disruptive blood flow, thereby indicating their importance and use in treatments in various therapeutic areas. According to JEMS (Journal of Emergency Medical Services), traumatic and non-traumatic causes of hemorrhage carry remarkable morbidity and mortality.

Rise in the geriatric population, increase in number of surgical procedures, research & developments, and advancements in the fields of healthcare and life sciences, rise in public health awareness and measures have led to the introduction of appropriate and effective treatments for diseases.Consistent rise in geriatric population requiring treatments in various therapeutic areas fuels the demand for hemostatic agents in order to prevent the disruptive blood loss.

This provides significant opportunity for key players operating in the market. Key players are introducing different strategies of launching products and acquisitions, along with appropriate marketing and strong distributors and hospitals network, thereby boosting the hemostatic agents market.

Acquisition and collaboration of related companies, along with the launch of new products after extensive research and development activities, has been a key strategy adopted by key players to strengthen their geographic presence in the last few years. Therefore, the players strive to gain competitive advantage in the market by opting for strategies such as agreements, partnerships and collaborations, and new product development.

The global hemostatic agents market has been broadly segmented based on product type, specialty / therapeutic area, size of hospitals, and region.In terms of product type, the global hemostatic market has been divided into active agents, passive agents, and combination.

The active agents segment, followed by the combination segment, is expected to expand during the forecast period.In terms of specialty / therapeutic area, the global hemostatic agents market has been classified into cardiology, cath lab, trauma, general surgery, obgyn, transplant, oncology, neurology, orthopedic, plastic surgery, dental, and others (urological surgeries, pulmonary surgeries).

General surgery, cardiology, and trauma, segments are expected to dominate the market during the forecast period due to the increase in number of patient population cases in these therapeutic areas.In terms of size of hospitals, the global hemostatic agents market has been divided into large hospitals (500+ bed size), medium hospital (250-499 beds), and small hospitals (less than 250 beds).

Large hospitals and medium hospitals segments are expected to hold a major share of the market during the forecast period.

In terms of region, the global hemostatic agents market has been segmented into North America, Europe, Asia Pacific, South Africa and Rest of World (RoW).North America and Europe holds a prominent share of the global hemostatic agents market.

The market in North America is primarily driven by the increase in geriatric population, rise in number of surgical procedures, and increase in patient population.The market in Asia Pacific is expected to expand at a significant growth rate during the forecast period.

The report also states key players in the market based on various attributes such as company overview, key business strategies, financial overview, recent developments, and product portfolio. Key players functioning in the global hemostatic agents market include Baxter, Ethicon US, LLC., C. R. Bard, Inc., B. Braun Melsungen AG, Pfizer Inc., Z-Medica, LLC., CryoLife, Inc., Integra LifeSciences, Advanced Medical Solutions Group plc, and GELITA AG.

The global hemostatic agents market has been segmented as mentioned below:

Global Hemostatic Agents Market, by Product Type
Active Agents
Passive Agents
Combination

Global Hemostatic Agents Market, by Specialty / Therapeutic Area
Cardiology
Cath Lab
Trauma
General Surgery
ObGyn
Transplant
Oncology
Neurology
Orthopedic
Plastic Surgery
Dental
Others (Urological Surgeries, Pulmonary Surgeries)

Global Hemostatic Agents Market, by Size of Hospitals
Large Hospitals (500+ bed size)
Medium Hospital (250-499 beds)
Small Hospitals (less than 250 beds)

Global Hemostatic Agents Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Australia
Japan
South Korea
Rest of Asia Pacific
South Africa
Rest of World (RoW)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
25% Off

$5795

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

ref:plp2018

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on